Predictors of Limb Fat Gain in HIV Positive Patients Following a Change to Tenofovir-Emtricitabine or Abacavir-Lamivudine

• Allison Martin ,

  * E-mail: ahumphries@kirby.unsw.edu.au

  Affiliation The Kirby Institute (formerly the National Centre in HIV Epidemiology and Clinical Research), University of New South Wales, Sydney, New South Wales, Australia

  ⨯
• Janaki Amin,

  Affiliation The Kirby Institute (formerly the National Centre in HIV Epidemiology and Clinical Research), University of New South Wales, Sydney, New South Wales, Australia

  ⨯
• Sean Emery,

  Affiliation The Kirby Institute (formerly the National Centre in HIV Epidemiology and Clinical Research), University of New South Wales, Sydney, New South Wales, Australia

  ⨯
• David Baker,

  Affiliation East Sydney Doctors, Sydney, New South Wales, Australia

  ⨯
• Andrew Carr,

  Affiliation St Vincent's Hospital and St Vincent's Centre for Applied Medical Research, Sydney, New South Wales, Australia

  ⨯
• David A. Cooper,

  Affiliation The Kirby Institute (formerly the National Centre in HIV Epidemiology and Clinical Research), University of New South Wales, Sydney, New South Wales, Australia

  ⨯
• Mark Bloch, on behalf of the STEAL study group

  Affiliation Holdsworth House Medical Practice, Sydney, New South Wales, Australia

  ⨯